Prothena Corp Public (PRTA) Revenue (2012 - 2026)
Prothena Corp Public (PRTA) posted quarterly Revenue of $51.1 million for Q1 2026, up 1706.36% year-over-year from $2.8 million in Q1 2025, and up 243157.14% quarter-over-quarter from $21000.0 in Q4 2025.
Analysis
Prothena Corp Public (PRTA) Revenue (2012 - 2026) Analysis & Trends
Prothena Corp Public's Revenue history runs 15 years deep, the most recent figure standing at $51.1 million for Q1 2026.
- In Q1 2026, Revenue rose 1706.36% year-over-year to $51.1 million; the TTM figure through Mar 2026 stood at $57.9 million (down 57.99% YoY), while the FY2025 annual figure was $9.7 million, down 92.83% from the prior year.
- Revenue for Q1 2026 stood at $51.1 million, up from $21000.0 in the prior quarter.
- The five-year high for Revenue was $132.0 million in Q2 2024, with the low at $21000.0 in Q4 2025.
- The 5-year median for Revenue is $2.2 million (2023), against an average of $20.1 million.
- The sharpest annual moves came in 2023 and 2025: Revenue slumped 99.37% in 2023, then jumped 5556.0% in 2025.
- Prothena Corp Public's Revenue stood at $49.9 million in 2022, then plunged by 99.37% to $316000.0 in 2023, then surged by 571.84% to $2.1 million in 2024, then slumped by 99.01% to $21000.0 in 2025, then soared by 243157.14% to $51.1 million in 2026.
- Business Quant data shows PRTA's Revenue at $51.1 million in Q1 2026, $21000.0 in Q4 2025, and $2.4 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn | 145.00 Mn |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 1.71 Bn |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn | 1.29 Bn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 674.14 Mn |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Prothena Corp Public | 509.98 Mn | 221.78 Mn | - | 1.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.01 Mn |
| Mar 31, 2026 | 51.08 Mn |
| Dec 31, 2025 | 21,000.00 |
| Sep 30, 2025 | 2.42 Mn |
| Jun 30, 2025 | 4.42 Mn |
| Mar 31, 2025 | 2.83 Mn |
| Dec 31, 2024 | 2.12 Mn |
| Sep 30, 2024 | 970,000.00 |
| Jun 30, 2024 | 132.01 Mn |
| Mar 31, 2024 | 50,000.00 |
| Dec 31, 2023 | 316,000.00 |
| Sep 30, 2023 | 84.87 Mn |
| Jun 30, 2023 | 4.02 Mn |
| Mar 31, 2023 | 2.17 Mn |
| Dec 31, 2022 | 49.92 Mn |
| Sep 30, 2022 | 1.52 Mn |
| Jun 30, 2022 | 1.31 Mn |
| Mar 31, 2022 | 1.15 Mn |
| Dec 31, 2021 | 1.17 Mn |
| Sep 30, 2021 | 139.17 Mn |